$40 million incentive lures global pharmaceutical giant to Parsippany
Teva will move North American HQ to New Jersey - Kansas City Business Journal
Teva Pharmaceuticals Successfully Defends Against Allegations of Patent Infringement | Parsippany Focus
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch | Reuters
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva agrees to pay $126 million to US hospitals over opioids | Reuters
Teva Pharmaceuticals moving HQ from Montgomery County to New Jersey – thereporteronline
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Teva recalls one lot of IDArubicin Hydrochloride Injection USP
FDA approves Teva's generic EpiPen after yearslong delay
Teva Will Pay Up to $126 Million to U.S. Hospitals Over Opioids - news.law
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva, one of the biggest generic makers, joins the the brand-name club
Teva stock plummets 18% after rough quarter in US generic drug market
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva down as it reports lower sales and profit for 2018
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Governor Phil Murphy signed a Proclamation welcoming Teva … | Flickr
